Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma

BACKGROUND: Lung squamous cell carcinoma (LUSC) represents 30% of all non-small cell lung carcinoma. Targeted therapy is not sufficient for LUSC patients because of the low frequency of targeted-effective mutation in LUSC whereas immunotherapy offers more options for patients with LUSC. We explored...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Chen, Yaokun, Gao, Wen, Feng, Hui, Zhang, Biyuan, Wang, Haiji, Lu, Haijun, Tan, Ye, Dong, Yinying, Xu, Mingjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330609/
https://www.ncbi.nlm.nih.gov/pubmed/35912252
http://dx.doi.org/10.3389/fonc.2022.933925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330609/
https://www.ncbi.nlm.nih.gov/pubmed/35912252
http://dx.doi.org/10.3389/fonc.2022.933925

Ejemplares similares